A study of more than 2,000 subjects at risk of Type 2 diabetes showed the drug metformin reduced the risk of developing the disease. Patients who adhered to the metformin regimen had a 38.2% reduced risk of developing diabetes compared to those who took a placebo.

Full Story:

Related Summaries